RETRACTION: Preparation of a pH-Responsive Chitosan-Montmorillonite-Nitrogen-Doped Carbon Quantum Dots Nanocarrier for Attenuating Doxorubicin Limitations in Cancer Therapy
IF 3.9 4区 生物学Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
{"title":"RETRACTION: Preparation of a pH-Responsive Chitosan-Montmorillonite-Nitrogen-Doped Carbon Quantum Dots Nanocarrier for Attenuating Doxorubicin Limitations in Cancer Therapy","authors":"","doi":"10.1002/elsc.70033","DOIUrl":null,"url":null,"abstract":"<p><b>RETRACTION</b>: E. Rahmani, M. Pourmadadi, S. A. Ghorbanian, F. Yazdian, H. Rashedi, and M. Navaee, “Preparation of a pH-Responsive Chitosan-Montmorillonite-Nitrogen-Doped Carbon Quantum Dots Nanocarrier for Attenuating Doxorubicin Limitations in Cancer Therapy,” <i>Engineering in Life Sciences</i> 22, no. 10 (2022): 634–649, https://doi.org/10.1002/elsc.202200016.</p><p>The above article, published online on 13 September 2022 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editors-in-Chief, Ralf Takors, An-Ping Zeng; and Wiley-VCH GmbH.</p><p>The partial raw data provided by the authors could not address the original concerns, showed inconsistencies with the published results, and ultimately raised additional doubts about the study's overall reliability. Consequently, the editors have lost confidence in the presented data and decided to retract the paper. The authors’ institute has been informed of the allegations and the decision to retract but remained unresponsive. The authors disagree with the retraction.</p>","PeriodicalId":11678,"journal":{"name":"Engineering in Life Sciences","volume":"25 7","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/elsc.70033","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Engineering in Life Sciences","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/elsc.70033","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
RETRACTION: E. Rahmani, M. Pourmadadi, S. A. Ghorbanian, F. Yazdian, H. Rashedi, and M. Navaee, “Preparation of a pH-Responsive Chitosan-Montmorillonite-Nitrogen-Doped Carbon Quantum Dots Nanocarrier for Attenuating Doxorubicin Limitations in Cancer Therapy,” Engineering in Life Sciences 22, no. 10 (2022): 634–649, https://doi.org/10.1002/elsc.202200016.
The above article, published online on 13 September 2022 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editors-in-Chief, Ralf Takors, An-Ping Zeng; and Wiley-VCH GmbH.
The partial raw data provided by the authors could not address the original concerns, showed inconsistencies with the published results, and ultimately raised additional doubts about the study's overall reliability. Consequently, the editors have lost confidence in the presented data and decided to retract the paper. The authors’ institute has been informed of the allegations and the decision to retract but remained unresponsive. The authors disagree with the retraction.
引用本文:E. Rahmani, M. Pourmadadi, S. a . Ghorbanian, F. Yazdian, H. Rashedi, M. Navaee,“ph响应壳聚糖-蒙脱石-氮掺杂碳量子点纳米载体的制备及其在肿瘤治疗中的应用”,生命科学工程,22,no。10 (2022): 634-649, https://doi.org/10.1002/elsc.202200016.The上述文章于2022年9月13日在线发表在Wiley online Library (wileyonlinelibrary.com)上,经主编Ralf Takors、曾安平;Wiley-VCH GmbH作者提供的部分原始数据无法解决最初的担忧,与已发表的结果不一致,最终引发了对该研究总体可靠性的额外质疑。因此,编辑们对所提供的数据失去了信心,决定撤回这篇论文。作者研究所已被告知这些指控和撤回决定,但仍未作出回应。作者不同意撤稿。
期刊介绍:
Engineering in Life Sciences (ELS) focuses on engineering principles and innovations in life sciences and biotechnology. Life sciences and biotechnology covered in ELS encompass the use of biomolecules (e.g. proteins/enzymes), cells (microbial, plant and mammalian origins) and biomaterials for biosynthesis, biotransformation, cell-based treatment and bio-based solutions in industrial and pharmaceutical biotechnologies as well as in biomedicine. ELS especially aims to promote interdisciplinary collaborations among biologists, biotechnologists and engineers for quantitative understanding and holistic engineering (design-built-test) of biological parts and processes in the different application areas.